A systematic review of mortality in schizophrenia: Is the differential mortality gap worsening over time?

Archives of General Psychiatry

Volumn 64, Issue 10, 2007, Pages 1123-1131

  Saha, Sukanta ^a   Chant, David ^a,b   McGrath, John ^a,b  

^a QUEENSLAND CENTRE FOR MENTAL HEALTH RESEARCH   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CAUSE OF DEATH; CLINICAL TRIAL; DATA ANALYSIS; HUMAN; META ANALYSIS; MORTALITY; REVIEW; RISK ASSESSMENT; SCHIZOPHRENIA; SUICIDE; SYSTEMATIC REVIEW;

ANTIPSYCHOTIC AGENTS; CAUSE OF DEATH; CROSS-CULTURAL COMPARISON; DATA COLLECTION; DEVELOPED COUNTRIES; FEMALE; FORECASTING; HEALTH STATUS; HUMANS; MALE; META-ANALYSIS; MORTALITY; RISK FACTORS; SCHIZOPHRENIA; SEX FACTORS; SUICIDE;

EID: 34948840329     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.64.10.1123     Document Type: Review

References (100)

1. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997;349(9063):1436-1442.
2. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 1997;349(9061):1269-1276.
3. Palmer BA, Pankratz VS, Bostwick JM. The lifetime risk of suicide in schizophrenia: a reexamination. Arch Gen Psychiatry. 2005;62(3):247-253.
4. Brown S. Excess mortality of schizophrenia: a meta-analysis. Br J Psychiatry. 1997;171:502-508.
5. Graunt J. Natural and political observations mentioned in a following index, and made upon the bills of mortality. In: Hunter RA, MacAlpine I, eds. Three Hundred Years of Psychiatry 1538-1860. London, England: Oxford University Press; 1963:1662-1666.
6. Kraepelin E. Dementia Praecox and Paraphrenia. Edinburgh, Scotland: Livingstone; 1919.
7. Alstrom CH. Mortality in mental hospitals with special regard to tuberculosis. Acta Psychiatr Neurol Scand Suppl. 1942:24.
8. Bleuler E. Dementia Paecox or the Group of Schizophrenias. New York, NY: International University Press; 1950.
9. Allebeck P. Schizophrenia: a life-shortening disease. Schizophr Bull. 1989;15(1):81-89.
10. Simpson JC. Mortality studies in schizophrenia. In: Tsuang MT, Simpson JC, eds. Handbook of Schizophrenia, Volume 3: Nosology, Epidemiology and Genetics of Schizophrenia. Amsterdam, the Netherlands: Elsevier; 1988:245-274.
11. Harris EC, Barraclough B. Excess mortality of mental disorder. Br J Psychiatry. 1998;173:11-53.
12. Dube KC, Kumar N, Dube S. Long term course and outcome of the Agra cases in the International Pilot Study of Schizophrenia. Acta Psychiatr Scand. 1984;70(2):170-179.
13. Brook OH. Mortality in the long-stay population of Dutch mental hospitals. Acta Psychiatr Scand. 1985;71(6):626-635.
14. Murray CJ, Lopez AD, Jamison DT. The global burden of disease in 1990: summary results, sensitivity analysis and future directions. Bull World Health Organ. 1994;72(3):495-509.
15. Department of Health and Ageing. National Mental Health Report 2005: Summary of Ten Years of Reform in Australia's Mental Health Services Under National Mental Health Strategy 1993-2003. Canberra: Commonwealth of Australia; 2005.
16. World Health Organization. The World Health Report 2001: Mental Health: New Understanding, New Hope. Geneva, Switzerland: World Health Organization; 2001.
17. Osby U, Correia N, Brandt L, Ekbom A, Sparen P. Time trends in schizophrenia mortality in Stockholm County, Sweden: cohort study. BMJ. 2000;321(7259):483-484.
18. Heilä H, Haukka J, Suvisaari J, Lonnqvist J. Mortality among patients with schizophrenia and reduced psychiatric hospital care. Psychol Med. 2005;35(5):725-732.
19. McGrath J, Saha S, Welham J, El Saadi O, MacCauley C, Chant D. A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Med. 2004;2(1):13.
20. Saha S, Chant D, Welham J, McGrath J. A systematic review of the prevalence of schizophrenia. PLoS Med. 2005;2(5):e141.
21. Greenland S. Meta-analysis. In: Rothman KJ, Greenland S, eds. Modern Epidemiology. 2nd ed. Sydney, Australia: Lippincott Williams & Wilkins; 1998: 643-674.
22. Räsänen S, Hakko H, Viilo K, Meyer-Rochow VB, Moring J. Excess mortality among long-stay psychiatric patients in Northern Finland. Soc Psychiatry Psychiatr Epidemiol. 2003;38(6):297-304.
23. Joukamaa M, Heliovaara M, Knekt P, Aromaa A, Raitasalo R, Lehtinen V. Mental disorders and cause-specific mortality. Br J Psychiatry. 2001;179:498-502.
24. Martin RL, Cloninger CR, Guze SB, Clayton PJ. Mortality in a follow-up of 500 psychiatric outpatients 1: total mortality. Arch Gen Psychiatry. 1985;42(1):47-54.
25. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB; Meta-analysis Of Observational Studies in Epidemiology (MOOSE) Group. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000;283(15):2008-2012.
26. Babidge NC, Buhrich N, Butler T. Mortality among homeless people with schizophrenia in Sydney, Australia: a 10-year follow-up. Acta Psychiatr Scand. 2001;103(2):105-110.
27. Kendler KS. A twin study of mortality in schizophrenia and neurosis. Arch Gen Psychiatry. 1986;43(7):643-649.
28. National Centre for Health Statistics. Mortality data from the National Vital Statistics System. In: International Classification of Diseases, Ninth Revision (ICD-9). http://www.cdc.gov/nchs/about/major/dvs/icd9des.htm. Accessed January 12, 2004.
29. Saha S, Welham J, Chant D, McGrath J. Incidence of schizophrenia does not vary with economic status of the country: evidence from a systematic review. Soc Psychiatry Psychiatr Epidemiol. 2006;41(5):338-340.
30. Central Intelligence Agency. CIA World Factbook 2004. Washington, DC: Central Intelligence Agency, Office of Public Affairs; 2004. http://www.cia.gov/cia/publications/factbook/. Accessed January 12, 2004.
31. Soubbotina TP. Beyond Economic Growth: An Introduction to Sustainable Development. 2nd ed. Washington, DC: World Bank; 2004.
32. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-560.
33. Allebeck P, Wistedt B. Mortality in schizophrenia: a ten-year follow-up based on the Stockholm County inpatient register. Arch Gen Psychiatry. 1986;43(7):650-653.
34. Amaddeo F, Bisoffi G, Bonizzato P, Micciolo R, Tansella M. Mortality among patients with psychiatric illness: a ten-year case register study in an area with a community-based system of care. Br J Psychiatry. 1995;166(6):783-788.
35. Baxter DN. The mortality experience of individuals on the Salford Psychiatric Case Register, I: all-cause mortality. Br J Psychiatry. 1996;168(6):772-779.
36. Black DW, Fisher R. Mortality in DSM-IIIR schizophrenia. Schizophr Res. 1992;7(2):109-116.
37. Buda M, Tsuang MT, Fleming JA. Causes of death in DSM-III schizophrenics and other psychotics (atypical group): a comparison with the general population. Arch Gen Psychiatry. 1988;45(3):283-285.
38. D'Avanzo B, La Vecchia C, Negri E. Mortality in long-stay patients from psychiatric hospitals in Italy: results from the Qualyop Project. Soc Psychiatry Psychiatr Epidemiol. 2003;38(7):385-389.
39. Montout C, Casadebaig F, Lagnaoui R, Verdoux H, Philippe A, Begaud B, Moore N. Neuroleptics and mortality in schizophrenia: prospective analysis of deaths in a French cohort of schizophrenic patients. Schizophr Res. 2002;57(2-3):147-156.
40. Ringbäck Weitoft G, Gullberg A, Rosen M. Avoidable mortality among psychiatric patients. Soc Psychiatry Psychiatr Epidemiol. 1998;33(9):430-437.
41. Simpson JC, Tsuang MT. Mortality among patientswith schizophrenia. Schizophr Bull. 1996;22(3):485-499.
42. Valenti M, Necozione S, Busellu G, Borrelli G, Lepore AR, Madonna R, Altobelli E, Mattei A, Torchio P, Corrao G, Di Orio F. Mortality in psychiatric hospital patients: a cohort analysis of prognostic factors. Int J Epidemiol. 1997;26(6):1227-1235.
43. Waddington JL, Youssef HA, Kinsella A. Mortality in schizophrenia: antipsychotic polypharmacy and absence of adjunctive anticholinergics over the course of a 10-year prospective study. Br J Psychiatry. 1998;173:325-329.
44. Anderson C, Connelly J, Johnstone EC, Owens DGC. Cause of death. Br J Psychiatry Suppl. 1991;13(13)(suppl 13):30-33.
45. Black DW. Mortality in schizophrenia: the Iowa Record-Linkage Study: a comparison with general population mortality. Psychosomatics. 1988;29(1):55-60.
46. Bralet MC, Yon V, Loas G, Noisette C. Mortality in schizophrenia: a 8-year follow-up study in 150 chronic schizophrenics. Encephale. 2000;26(6):32-41.
47. Brown S, Inskip H, Barraclough B. Causes of the excess mortality of schizophrenia. Br J Psychiatry. 2000;177:212-217.
48. Casadebaig F, Philippe A. Mortality among schizophrenic patients. Encephale. 1999;25(4):329-337.
49. Chen WJ, Huang YJ, Yeh LL, Rin H, Hwu HG. Excess mortality of psychiatric inpatients in Taiwan. Psychiatry Res. 1996;62(3):239-250.
50. Curkendall SM, Mo J, Glasser DB, Rose Stang M, Jones JK. Cardiovascular disease in patients with schizophrenia in Saskatchewan, Canada. J Clin Psychiatry. 2004;65(5):715-720.
51. Eastwood MR, Stiasny S, Meier HM, Woogh CM. Mental illness and mortality. Compr Psychiatry. 1982;23(4):377-385.
52. Hansen V, Arnesen E, Jacobsen BK. Total mortality in people admitted to a psychiatric hospital. Br J Psychiatry. 1997;170:186-190.
53. Harrison G, Hopper K, Craig T, Laska E, Siegel C, Wanderling J, Dube KC, Ganev K, Giel R, an der Heiden W, Holmberg SK, Janca A, Lee PW, León CA, Malhotra S, Marsella AJ, Nakane Y, Sartorius N, Shen Y, Skoda C, Thara R, Tsirkin SJ, Varma VK, Walsh D, Wiersma D. Recovery from psychotic illness: a 15- and 25-year international follow-up study. Br J Psychiatry. 2001;178:506-517.
54. Hassall C, Prior P, Cross KW. A preliminary study of excess mortality using a psychiatric case register. J Epidemiol Community Health. 1988;42(3):286-289.
55. Haugland G, Craig TJ, Goodman AB, Siegel C. Mortality in the era of deinstitutionalization. Am J Psychiatry. 1983;140(7):848-852.
56. Herrman HE, Baldwin JA, Christie D. A record-linkage study of mortality and general hospital discharge in patients diagnosed as schizophrenic. Psychol Med. 1983;13(3):581-593.
57. Hewer W, Rossler W. Mortality of patients with functional psychiatric illnesses during inpatient treatment [in German]. Fortschr Neurol Psychiatr. 1997;65(4):171-181.
58. Kurihara T, Kato M, Kashima H, Takebayashi T, Reverger R, Tirta IGR. Excess mortality of schizophrenia in the developing country of Bali. Schizophr Res. 2006;83(1):103-105.
59. Lawrence D, Jablensky AV, Holman CDJ, Pinder TJ. Mortality in Western Australian psychiatric patients. Soc Psychiatry Psychiatr Epidemiol. 2000;35(8):341-347.
60. Lesage AD, Trapani V, Tansella M. Excess mortality by natural causes of Italian schizophrenic patients. Eur Arch Psychiatry Neurol Sci. 1990;239(6):361-365.
61. Menezes PR, Mann AH. Mortality among patients with non-affective functional psychoses in a metropolitan area of south-eastern Brazil. Rev Saude Publica. 1996;30(4):304-309.
62. Morgan MG, Scully PJ, Youssef HA, Kinsella A, Owens JM, Waddington JL. Prospective analysis of premature mortality in schizophrenia in relation to health service engagement: a 7.5-year study within an epidemiologically complete, homogeneous population in rural Ireland. Psychiatry Res. 2003;117(2):127-135.
63. Mortensen PB, Juel K. Mortality and causes of death in schizophrenic patients in Denmark. Acta Psychiatr Scand. 1990;81(4):372-377.
64. Mortensen PB, Juel K. Mortality and causes of death in first admitted schizophrenic patients. Br J Psychiatry. 1993;163:183-189.
65. Newman SC, Bland RC. Mortality in a cohort of patients with schizophrenia: a record linkage study. Can J Psychiatry. 1991;36(4):239-245.
66. Osby U, Correia N, Brandt L, Ekbom A, Sparen P. Mortality and causes of death in schizophrenia in Stockholm County, Sweden. Schizophr Res. 2000;45(1-2):21-28.
67. Politi P, Piccinelli M, Klersy C, Madini S, Segagni LG, Fratti C, Barale F. Mortality in psychiatric patients 5 to 21 years after hospital admission in Italy. Psychol Med. 2002;32(2):227-237.
68. Ruschena D, Mullen PE, Burgess P, Cordner SM, Barry-Walsh J, Drummer OH, Palmer S, Browne C, Wallace C. Sudden death in psychiatric patients. Br J Psychiatry. 1998;172:331-336.
69. Saku M, Tokudome S, Ikeda M, Kono S, Makimoto K, Uchimura H, Mukai A, Yoshimura T. Mortality in psychiatric patients, with a specific focus on cancer mortality associated with schizophrenia. Int J Epidemiol. 1995;24(2):366-372.
70. Tsuang MT, Woolson RF, Fleming JA. Causes of death in schizophrenia and manic-depression. Br J Psychiatry. 1980;136:239-242.
71. Tsuzuki H, Yuasa S. An epidemiological study of deaths in mental hospitals [author's transl] [in Japanese]. Seishin Shinkeigaku Zasshi. 1981;83(5):275-304.
72. Wood JB, Evenson RC, Cho DW, Hagan BJ. Mortality variations among public mental health patients. Acta Psychiatr Scand. 1985;72(3):218-229.
73. Zilber N, Schufman N, Lerner Y. Mortality among psychiatric patients - the groups at risk. Acta Psychiatr Scand. 1989;79(3):248-256.
74. Wamala S, Blakely T, Atkinson J. Trends in absolute socioeconomic inequalities in mortality in Sweden and New Zealand: a 20-year gender perspective. BMC Public Health. 2006;6:164.
75. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997;349(9064):1498-1504.
76. Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970-2002. JAMA. 2005;294(10):1255-1259.
77. Leucht S, Barnes TR, Kissling W, Engel RR, Correll C, Kane JM. Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials. Am J Psychiatry. 2003;160(7):1209-1222.
78. Leucht S, Wahlbeck K, Hamann J, Kissling W. New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis. Lancet. 2003;361(9369):1581-1589.
79. Awad AG, Voruganti LN. Impact of atypical antipsychotics on quality of life in patients with schizophrenia. CNS Drugs. 2004;18(13):877-893.
80. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353(12):1209-1223.
81. Jones PB, Barnes TR, Davies L, Dunn G, Lloyd H, Hayhurst KP, Murray RM, Markwick A, Lewis SW. Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Arch Gen Psychiatry. 2006;63(10):1079-1087.
82. Hennekens CH, Hennekens AR, Hollar D, Casey DE. Schizophrenia and increased risks of cardiovascular disease. Am Heart J. 2005;150(6):1115-1121.
83. Remington G. Schizophrenia, antipsychotics, and the metabolic syndrome: is there a silver lining? Am J Psychiatry. 2006;163(7):1132-1134.
84. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288(21):2709-2716.
85. Allison DB, Casey DE. Antipsychotic-induced weight gain: a review of the literature. J Clin Psychiatry. 2001;62(Suppl 7):22-31.
86. Fontaine KR, Heo M, Harrigan EP, Shear CL, Lakshminarayanan M, Casey DE, Allison DB. Estimating the consequences of anti-psychotic induced weight gain on health and mortality rate. Psychiatry Res. 2001;101(3):277-288.
87. Aleman A, Kahn RS, Selten JP. Sex differences in the risk of schizophrenia: evidence from meta-analysis. Arch Gen Psychiatry. 2003;60(6):565-571.
88. Castle DJ. Sex differences in brain development, organisation and degeneration: are they relevant to sex differences in schizophrenia? In: Castle DJ, McGrath J, Kulkarni J, eds. Women and Schizophrenia. Cambridge, MA: Cambridge University Press; 2000:5-18.
89. Cohen M, Dembling B, Schorling J. The association between schizophrenia and cancer: a population-based mortality study. Schizophr Res. 2002;57(2-3):139-146.
90. Coghlan R, Lawrence D, Jablensky A. Duty to Care: Physical Illness in People with Mental Illness. Perth: The University of Western Australia; 2001.
91. Murray CJ, Lopez AD. Global and regional cause-of-death patterns in 1990. Bull World Health Organ. 1994;72(3):447-480.
92. Mitchell AJ, Malone D. Physical health and schizophrenia. Curr Opin Psychiatry. 2006;19(4):432-437.
93. Eaton WW, Byrne M, Ewald H, Mors O, Chen CY, Agerbo E, Mortensen PB. Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am J Psychiatry. 2006;163(3):521-528.
94. Gough SC, O'Donovan MC. Clustering of metabolic comorbidity in schizophrenia: a genetic contribution? J Psychopharmacol. 2005;19(6)(suppl):47-55.
95. McClellan JM, Susser E, King MC. Maternal famine, de novo mutations, and schizophrenia. JAMA. 2006;296(5):582-584.
96. Barker DJ. Maternal nutrition, fetal nutrition, and disease in later life. Nutrition. 1997;13(9):807-813.
97. Barker DJ, Clark PM. Fetal undernutrition and disease in later life. Rev Reprod. 1997;2(2):105-112.
98. Marder SR, Essock SM, Miller AL, Buchanan RW, Casey DE, Davis JM, Kane JM, Lieberman JA, Schooler NR, Covell N, Stroup S, Weissman EM, Wirshing DA, Hall CS, Pogach L, Pi-Sunyer X, Bigger JT Jr, Friedman A, Kleinberg D, Yevich SJ, Davis B, Shon S. Physical health monitoring of patients with schizophrenia. Am J Psychiatry. 2004;161(8):1334-1349.
99. World Health Organization. Manual of the Statistical International Classification of Diseases, Injuries, and Causes of Death, 1975 Revision. Vol 1. Geneva, Switzerland: World Heath Organization; 1977.
100. Goldacre MJ, Duncan ME, Griffith M, Cook-Mozaffari P. Psychiatric disorders certified on death certificates in an English population. Soc Psychiatry Psychiatr Epidemiol. 2006;41(5):409-414.